+ |
CHEK2 | up-regulates
phosphorylation
|
VHL |
0.467 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-177091 |
Ser111 |
GTGRRIHsYRGHLWL |
Homo sapiens |
Kidney Cancer Cell |
pmid |
sentence |
22071692 |
We demonstrated that checkpoint kinase-2 (chk2) binds to the beta-domain of pvhl and phosphorylates ser 111 on dna damage. Notably, this modification enhances pvhl-mediated transactivation of p53 by recruiting p300 and tip60 to the chromatin of p53 target gene |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
NEK1 | down-regulates quantity by destabilization
phosphorylation
|
VHL |
0.26 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-276434 |
Ser168 |
RCLQVVRsLVKPENY |
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
23255108 |
Nek1 phosphorylates Von Hippel-Lindau tumor suppressor to promote its proteasomal degradation and ciliary destabilization. Mutation of pVHL at S-168 increases protein stability. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
VHL | down-regulates activity
binding
|
CARD9 |
0.402 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-266899 |
|
|
Homo sapiens |
HeLa Cell |
pmid |
sentence |
17936701 |
We found that pVHL associates with the NF-kappaB agonist Card9 but does not target Card9 for destruction. Instead, pVHL serves as an adaptor that promotes the phosphorylation of the Card9 C terminus by CK2. |
|
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-257603 |
|
|
Homo sapiens |
HeLa Cell |
pmid |
sentence |
17936701 |
We found that pVHL associates with the NF-kappaB agonist Card9 but does not target Card9 for destruction. Instead, pVHL serves as an adaptor that promotes the phosphorylation of the Card9 C terminus by CK2. |
|
Publications: |
2 |
Organism: |
Homo Sapiens |
+ |
VHL | up-regulates quantity by expression
transcriptional regulation
|
CDKN1C |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-255601 |
|
|
Homo sapiens |
Renal Cell Carcinoma Cell |
pmid |
sentence |
15824735 |
three of the nine targets had been identified previously as candidate TSGs (DOC-2/DAB2, CDKN1C and SPARC) and all were upregulated by wild-type pVHL. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
VHL | down-regulates quantity by repression
transcriptional regulation
|
KLF10 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-253213 |
|
|
Homo sapiens |
RCC 786-O Cell |
pmid |
sentence |
18359287 |
In this study, we show that both TGFBI and KLF10 are down-regulated by VHL in 786-0 cells, and that KLF10 may serve as a transactivator of the TGFBI promoter. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
VHL | up-regulates quantity by stabilization
binding
|
TP53 |
0.464 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-256594 |
|
|
Homo sapiens |
HEK-293 Cell |
pmid |
sentence |
16678111 |
Here we found that pVHL directly associates with and stabilizes p53 by suppressing Mdm2-mediated ubiquitination and nuclear export of p53. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
VHL | down-regulates quantity by destabilization
ubiquitination
|
IREB2 |
0.366 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-271421 |
|
|
Homo sapiens |
RCC 786-O Cell |
pmid |
sentence |
15777842 |
We show here that IRP2 can interact with pVHL in co-transfection/co-immunoprecipitation assays. Furthermore, pVHL is able to promote the ubiquitination and the decay of transfected IRP2. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
VHL | form complex
binding
|
VCB-Cul2 |
0.818 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-272585 |
|
|
Homo sapiens |
|
pmid |
sentence |
11574546 |
The von Hippel-Lindau tumor-suppressor protein (pVHL) forms a protein complex (VCB-Cul2) with elongin C, elongin B, Cul-2, and Rbx1, which functions as a ubiquitin-protein ligase (E3). The alpha-subunits of the hypoxia-inducible factors have been identified as targets for the VCB-Cul2 ubiquitin ligase. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
VHL | up-regulates quantity by expression
transcriptional regulation
|
DAB2 |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-255602 |
|
|
Homo sapiens |
Renal Cell Carcinoma Cell |
pmid |
sentence |
15824735 |
three of the nine targets had been identified previously as candidate TSGs (DOC-2/DAB2, CDKN1C and SPARC) and all were upregulated by wild-type pVHL. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
VHL | up-regulates quantity by expression
transcriptional regulation
|
SPARC |
0.2 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-255603 |
|
|
Homo sapiens |
Renal Cell Carcinoma Cell |
pmid |
sentence |
15824735 |
three of the nine targets had been identified previously as candidate TSGs (DOC-2/DAB2, CDKN1C and SPARC) and all were upregulated by wild-type pVHL. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |
+ |
VHL | down-regulates
ubiquitination
|
HIF-1 complex |
0.683 |
Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-80969 |
|
|
Homo sapiens |
|
pmid |
sentence |
10944113 |
Here we show that the product of the von hippel-lindau (vhl) tumor suppressor gene mediated ubiquitylation and proteasomal degradation of hif-1 alpha under normoxic conditions via interaction with the core of the oxygen-dependent degradation domain of hif-1 alpha. |
|
Publications: |
1 |
Organism: |
Homo Sapiens |